Related content

Serotonin and dopamine receptor gene polymorphisms and the risk of extrapyramidal side effects in perphenazine-treated schizophrenic patients

By Gunes Arzu   Scordo Maria   Jaanson Peeter   Dahl Marja-Liisa  

Psychopharmacology, Vol. 190, Iss. 4, 2007-03 ,pp. : 479-484

Springer Publishing Company

Access to resources Recommend Favorite

genotype and antipsychotic-induced extrapyramidal side effects in schizophrenic patients

By Scordo M.G.   Spina E.   Romeo P.   Dahl M.-L.   Bertilsson L.   Johansson I.   Sjöqvist F.  

European Journal of Clinical Pharmacology, Vol. 56, Iss. 9-10, 2000-12 ,pp. : 679-683

Springer Publishing Company

Access to resources Recommend Favorite

Association Between 5HT1b Receptor Gene and Methamphetamine Dependence

By  

Current Neuropharmacology, Vol. 9, Iss. 1, 2011-03 ,pp. : 163-168

Bentham Science Publishers

Access to resources Recommend Favorite

The effect of vitamin E addition to acute neuroleptic treatment on the emergence of extrapyramidal side effects in schizophrenic patients: An open label study

By Dorfman-Etrog P.   Hermesh H.   Prilipko L.   Weizman A.   Munitz H.  

European Neuropsychopharmacology, Vol. 9, Iss. 6, 1999-12 ,pp. : 475-477

Elsevier

Access to resources Recommend Favorite

Lack of association between the 5HT 2A receptor polymorphism (T102C) and unipolar affective disorder in a multicentric European study

By Oswald P.   Souery D.   Massat I.   Del-Favero J.   Linotte S.   Papadimitriou G.   Dikeos D.   Kaneva R.   Milanova V.   Oruc L.   Ivezic S.   Serretti A.   Lilli R.   Van Broeckhoven C.   Mendlewicz J.  

European Neuropsychopharmacology, Vol. 13, Iss. 5, 2003-10 ,pp. : 365-368

Elsevier

Access to resources Recommend Favorite